Skip to main content

simponi

Patients With Ulcerative Colitis Show Improvement With New Drug
By Catherine Roberts Trending Health News

Patients With Ulcerative Colitis Show Improvement With New Drug

According to a clinical trial, more patients with an inflammatory disease of the bowels responded to autoimmune disorder drugs than those taking a placebo. Johnson & Johnson said findings of a trial showed that more patients with severely active ulcerative colitis responded to their drug Simponi (golimumab). The responsiveness to the drug was maintained right […]

Read More about Patients With Ulcerative Colitis Show Improvement With New Drug

1 min read